Physician profile
Areeba Sadiq
NPI 1619354164
$27,907.25
in general payments reported to CMS, 2019-2025
8 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25K · 2021: $669 · 2022: $303 · 2023: $731 · 2024: $396 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,983.45 | 2020-2025 | General - Kidney Stone Disease, Lithovue |
| Bayer Healthcare Pharmaceuticals INC. | $253.19 | 2023-2024 | |
| Teleflex LLC | $189.83 | 2023 | Urolift |
| Procept Biorobotics Corporation | $168.56 | 2021-2025 | |
| Palette Life Sciences, INC. | $157.19 | 2020-2022 | |
| Coloplast Corp | $103.26 | 2024 | |
| Shionogi INC | $28.98 | 2024 | Fetroja |
| Cook Medical LLC | $22.79 | 2023 | Lunderquist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Areeba Sadiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.